Siemens Healthineers To Spend €160M Building R&D And Manufacturing Hub In India
The company is the second big medtech to announce a major investment in R&D in the country in 2020.
You may also be interested in...
Medtechs took a long look at themselves as they rose to the challenges of COVID-19. How they responded, repurposed and regrouped to tackle the coronavirus was both sobering and uplifting. The lessons of 2020 must be integrated into the digitally-enabled health care systems of 2021 and beyond.
Five-year investment will expand R&D center in Hyderabad and add 1,000 to workforce.
Siemens Healthineers ̶ an engineering company by background – sees itself well positioned to benefit from the markets’ movement towards digital, workflows, robotics and minimally-invasive procedures. As such, it has advantages over pharma companies in being able to deliver better patient outcomes at lower cost and more effectively.